Lipid Management for the Prevention of Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|9|852-860

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.9, 2011-03, pp. : 852-860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Management Strategies for the Prevention of Adverse Cardiovascular Events

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 159-161

Karger

Access to resources Recommend Favorite

Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges

By Robinson Jennifer G.  

Drugs & Aging, Vol. 26, Iss. 11, 2009-11 ,pp. : 917-931

Adis International

Access to resources Recommend Favorite

Lipid Lowering for Secondary Prevention of Cardiovascular Disease in Older Adults

By Thomas Joseph E.  

Drugs & Aging, Vol. 27, Iss. 12, 2010-12 ,pp. : 959-972

Adis International

Access to resources Recommend Favorite

Cardiovascular risk in chronic renal disease and transplantation prevention and management

By Malyszko Jolanta   Malyszko Jacek S   Bachorzewska-Gajewska Hanna  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 929-943

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical thrombosis prevention in cardiovascular disease

By Eriksson Mats   Christensen Kjeld   Lindahl Tomas L   Larsson Anders  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 553-563

Informa Healthcare

Access to resources Recommend Favorite